Contineum Therapeutics Inc

Business

Analysts’ expectations for Contineum Therapeutics Inc (CTNM) stock: $17.5 price target in 12 months

Ulysses Smith

At the time of writing, Contineum Therapeutics Inc [CTNM] stock is trading at $11.74, down -0.84%. In order to assess ...

Business

Here is how Contineum Therapeutics Inc (CTNM) stock might take investors finances to the next level

Ulysses Smith

Contineum Therapeutics Inc [CTNM] stock prices are up 3.01% to $12.68 at the moment. Until recently, the best way to ...

MZP News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.